Fatty liver disease assessment
A staged assessment to confirm fatty liver, look for scarring, and address the underlying causes through lifestyle and risk factors.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Fatty liver (MASLD, formerly NAFLD) is common and usually low risk, but a minority develop scarring that needs identifying.
- Routine liver blood tests do not reliably detect scarring, so specific fibrosis tests such as FIB-4, ELF or a FibroScan are used.
- The assessment is staged over weeks: confirm fat, exclude other causes, then check for scarring.
- Treatment is lifestyle-first — weight, activity, diabetes, cholesterol and alcohol — and these can improve the liver.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Confirms whether fat in the liver is the explanation, and rules out other causes
Using routine liver blood tests alone to rule out scarring, which they cannot reliably do.
An ultrasound and blood tests confirm fatty change and exclude other causes. You can carry on as normal after each test.
A clear explanation of your scarring risk and what it means.
An ultrasound and blood tests confirm fatty change and exclude other causes. You can carry on as normal after each...
A FIB-4 score, and often an ELF test or FibroScan, estimate your risk of advanced fibrosis.
Results are combined with your risk factors into an overall picture, and a plan is agreed.
You work on weight, activity, diabetes, blood pressure, cholesterol and alcohol, which can improve the liver over...
What is a fatty liver disease (NAFLD / MASLD) assessment?
Fatty liver disease means extra fat building up in the liver in people who do not drink harmful amounts of alcohol. It is increasingly called metabolic dysfunction-associated steatotic liver disease, or MASLD, because it is closely linked to weight, type 2 diabetes, high blood pressure and cholesterol. The older name was non-alcoholic fatty liver disease (NAFLD).
An assessment is not a single test. It usually confirms that fat is present, often on an ultrasound, looks for other causes of liver problems, and then focuses on the key question: is there scarring (fibrosis) in the liver? Most people with fatty liver have a low risk of serious liver problems, but a minority develop inflammation (steatohepatitis, MASH or NASH) and scarring that can progress.
Because routine liver blood tests are unreliable for detecting scarring, UK guidance recommends specific fibrosis tests, such as the FIB-4 score or the enhanced liver fibrosis (ELF) blood test, and a FibroScan, to find the people most at risk.
The most important part of the assessment is what it leads to: addressing the underlying causes. Fatty liver is largely a lifestyle and metabolic condition, and weight loss, more activity, good diabetes and cholesterol control, and staying within alcohol limits can improve the liver and often the results.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Tests used to check for scarring in fatty liver
| Test | What it is | Key limitation |
|---|---|---|
| Routine liver bloods | ALT, AST and others | Do not reliably detect scarring |
| FIB-4 | Calculation from bloods | A screening estimate, not a diagnosis |
| ELF blood test | Specialised blood markers | Needs a specific test and cut-off |
| FibroScan | Liver stiffness scan | Can fail or mislead in obesity |
| Biopsy | Tissue sample | Invasive; small risks; sampling error |
No single non-invasive test is perfect. UK guidance uses them in steps, and results are interpreted together with your history and risk factors.
Preparing for your test
- Note your typical alcohol intake honestly in units per week, as this changes how the liver picture is interpreted.
- Bring details of weight history, type 2 diabetes, blood pressure and cholesterol, which are central to fatty liver.
- List all medicines and supplements, including any 'liver' or 'detox' products.
- Ask whether fasting is needed for the ultrasound or any blood tests.
- For a FibroScan, you will usually be asked not to eat for a few hours beforehand.
- Bring previous liver blood tests and any scan reports for comparison.
- Note any family history of liver disease, diabetes or heart disease.
What happens
The assessment is usually staged. First, fatty change is confirmed, often on an ultrasound, and a liver screen checks there is no other cause. Routine bloods may be mildly abnormal or even normal.
Next comes the key step: looking for scarring. A FIB-4 score is often calculated from routine bloods as a first filter. People at higher risk may then have an ELF blood test or a FibroScan, which measures how stiff the liver is. These are combined to estimate whether advanced fibrosis is likely.
Alongside this, your weight, diabetes, blood pressure and cholesterol are reviewed, because fatty liver is part of a wider metabolic picture and these also affect your heart.
Finally, a plan is agreed. For most people this centres on lifestyle change and managing risk factors, with monitoring over time. A minority with signs of advanced scarring are referred to a liver specialist for closer assessment and surveillance.
Is this test right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Using routine liver blood tests alone to rule out scarring, which they cannot reliably do.
- A one-off assessment with no plan to address weight, diabetes, cholesterol or alcohol.
- Relying on a FibroScan in isolation, particularly where a high body size may make it unreliable.
- Treating fatty liver as harmless without checking for the minority who have scarring.
Delay or rearrange if…
- A recent illness, heavy drinking or new medicine could distort liver blood tests.
- Liver blood tests have not yet been repeated to confirm a persistent abnormality.
- You have not fasted as instructed for an ultrasound or FibroScan.
- You are acutely unwell with jaundice, confusion or severe pain, which needs urgent care first.
Alternatives to discuss
- Lifestyle change and risk-factor management as the primary approach for most people.
- Stepwise non-invasive testing (FIB-4, then ELF or FibroScan) rather than a biopsy.
- NHS pathway rather than private, where waiting times are acceptable.
- Specialist referral where advanced scarring is suspected.
- Dietetic, diabetes or weight-management support as part of treatment.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Confirms whether fat in the liver is the explanation, and rules out other causes
- Identifies the minority with scarring who most need specialist care
- Uses non-invasive tests, often avoiding a biopsy
- Highlights linked risks to the heart, diabetes and blood pressure
- Gives a clear, lifestyle-first plan that can improve the liver
- Provides a baseline to track improvement or progression over time
Risks & complications
- Mild discomfort or bruising from blood tests
- Needing to fast for the ultrasound or FibroScan
- Being given a clear message that weight, diet, alcohol and activity need to change
- Anxiety while several tests are combined into a picture
- Mildly abnormal or even normal blood tests that do not settle the question of scarring
- A FibroScan that fails or gives an unreliable reading, more likely with a higher body size
- Borderline fibrosis results that need repeating or specialist interpretation
- Referral for a liver biopsy if non-invasive tests are unclear
- Finding advanced scarring or cirrhosis, which is important but can be distressing
- Detecting a liver lump on imaging that needs further tests
The main pitfalls are false reassurance and missed scarring. Routine liver blood tests can be normal even when fibrosis is present, so they should not be used alone to rule out scarring. FibroScan and ELF have limits too, and can be unreliable in some people. Ask which fibrosis tests are being used, what your results suggest, and what the plan is if they are borderline.
Published figures to discuss
The assessment itself is low risk. The important figures concern how well fibrosis tests perform. No single non-invasive test is perfect: routine blood tests can be normal despite scarring, FibroScan can fail or mislead in some people, and cut-offs such as the ELF score are thresholds, not certainties. Most people with fatty liver have a low risk of serious liver disease, but a minority progress, so results guide risk rather than give a definite outcome.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| FibroScan failure or unreliable reading | Reported in around 5% of scans, mainly in people with a higher body size | A failed or unreliable scan may need repeating or a different test. Figures vary between studies and settings. | NICE NG49 — Non-alcoholic fatty liver disease (NAFLD): assessment and managementnice.org.ukPublished figure |
| Advanced fibrosis on the ELF blood test | NICE uses an ELF score of 10.51 or above to indicate advanced fibrosis in fatty liver | This is a threshold to guide referral and monitoring, not a guarantee; results are interpreted with other tests. | NICE NG49 — Non-alcoholic fatty liver disease (NAFLD): assessment and managementnice.org.ukSource-linked context |
| Fatty liver in the adult population | Common; often estimated around 25% globally | Common does not mean harmless; fibrosis stage is the main prognostic issue. | NICE NG49 — Non-alcoholic fatty liver disease (NAFLD): assessment and managementnice.org.ukPublished figure |
| Weight loss needed for meaningful liver-fat and inflammation improvement | Often around 7 to 10% body-weight loss for larger histological benefits | Smaller changes can still help metabolic risk, but fibrosis improvement usually needs sustained change. | NICE NG49 — Non-alcoholic fatty liver disease (NAFLD): assessment and managementnice.org.ukPublished figure |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery from the assessment itself. What matters afterwards is understanding your scarring risk, acting on the lifestyle plan, and being monitored over time.
- No after-effects from the tests themselves
- Waiting a few weeks for the full picture to come together
- Being asked to make sustained lifestyle changes
- Slow, gradual improvement in blood tests with weight loss
- Periodic reassessment rather than a one-off discharge
Aftercare
- Start the agreed lifestyle changes: gradual weight loss if needed, more activity, and staying within alcohol limits.
- Keep diabetes, blood pressure and cholesterol well controlled, as these affect the liver and the heart.
- Avoid unproven 'liver detox' products and unnecessary supplements.
- Attend any FibroScan, ELF test or specialist referral that is arranged.
- Keep your repeat blood tests so progress can be tracked.
- Discuss any new medicines with your clinician, as some affect the liver.
- Ask when your fibrosis risk should be reassessed.
- Honest note of alcohol intake in units per week
- Weight history and metabolic conditions noted
- Full medicine and supplement list ready
- Fasting requirements for ultrasound and FibroScan checked
- Previous liver results and scan reports gathered
- Family history of liver, diabetes and heart disease noted
- Clear on which fibrosis tests are planned and when results are due
⚠ Get urgent help if…
- Yellowing of the skin or whites of the eyes (jaundice)
- Vomiting blood or passing black, tarry stools — seek emergency care
- A rapidly swelling tummy or new leg swelling with breathlessness
- Confusion, marked drowsiness or disorientation
- Severe or persistent upper-right tummy pain
- Unexplained weight loss, loss of appetite or feeling very unwell
- Severe itching that affects sleep
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good outcome from the assessment is a clear answer to two questions: is this fatty liver, and is there significant scarring? For most people the reassuring finding is fatty liver with little or no fibrosis, which can improve with weight loss, activity and good control of diabetes, blood pressure and cholesterol.
The assessment cannot promise that the liver will never progress, and no single non-invasive test is perfect. Routine blood tests can be normal despite scarring, and FibroScan and ELF have limits. The most powerful 'result' is often what you do next, because fatty liver is largely reversible in its early stages. Ask your clinician what your scarring risk is, what would change it, and how you will be monitored.
Fatty liver is a long-term, changing condition. Liver fat and scarring risk can improve with sustained lifestyle change, or worsen if weight, diabetes or alcohol are not addressed. Because of this, fibrosis risk is usually reassessed over time rather than checked once. UK guidance suggests rechecking advanced fibrosis risk periodically, for example every few years in lower-risk people, with closer monitoring for those at higher risk.
Related tests, treatments or support
A fatty liver assessment usually combines liver blood tests, a liver screen, an ultrasound, and fibrosis tests such as FIB-4, ELF or a FibroScan. It sits alongside broader health checks for diabetes, blood pressure, cholesterol and cardiovascular risk, because these are closely linked. Where needed, an MRI or, occasionally, a biopsy adds further detail.
Follow-up & long-term care
You should be told your scarring risk, the lifestyle plan, and when you will be reassessed. Lower-risk people are usually monitored in primary care with periodic fibrosis checks; higher-risk people are referred to a liver specialist for closer follow-up and, where appropriate, surveillance. If your liver blood tests or risk factors change, the plan may be reviewed sooner.
- Sustained lifestyle changes: weight management, activity and alcohol within limits
- Good control of type 2 diabetes, blood pressure and cholesterol
- Periodic reassessment of fibrosis risk, often every few years in lower-risk people
- Repeat liver blood tests to track progress over time
- Specialist surveillance if advanced scarring or cirrhosis is found
Repeat, follow-on and what comes next
- Borderline fibrosis results often need repeating or specialist interpretation.
- Fibrosis risk is reassessed over time, as it can improve or worsen.
- A biopsy is occasionally needed when non-invasive tests are unclear or conflict.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear explanation of your scarring risk and what it means.
- A practical, lifestyle-first plan with access to dietetic, diabetes or weight-management support.
- A defined interval for reassessing fibrosis risk, with a named route for results.
- Prompt specialist referral and surveillance where advanced scarring is found.
- Clear advice on warning signs that should prompt urgent help.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- How many blood tests and which fibrosis tests (FIB-4, ELF) are included
- Whether an ultrasound and a FibroScan are part of the package
- Whether specialist review by a hepatologist is included
- The clinic or hospital used and reporting speed
- Number of follow-up appointments and repeat tests over time
- Any onward imaging, such as MRI, or a biopsy if needed
- Whether lifestyle, dietetic or diabetes support is included
- Exactly which blood tests, scans and fibrosis tests are included
- Whether a FibroScan and ELF test are part of the price
- Whether a clinician interprets all the results together
- How and when results are delivered, and whether copies are provided
- Whether follow-up appointments and repeat fibrosis checks are included
- The cancellation and rebooking policy
- What happens, and what it costs, if advanced scarring is found and specialist care or a biopsy is needed
On the NHS? Fatty liver is routinely assessed on the NHS, often starting with a GP and using a staged fibrosis pathway; private assessment is also available, but the same approach of confirming fat, excluding other causes and checking for scarring applies.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Implying normal liver blood tests rule out scarring.
- Not explaining the limits of FibroScan and ELF, including unreliable results.
- Giving a diagnosis or reassurance before other causes have been excluded.
- No clear lifestyle plan or follow-up for reassessing scarring risk.
- Selling unproven 'liver detox' treatments alongside the assessment.
Marketing red flags
- Promising to 'reverse fatty liver' with supplements or detox products.
- Offering a single scan as a complete answer to scarring risk.
- Implying normal blood tests mean the liver is definitely healthy.
- Pushing medicines or treatments without addressing weight, diabetes and alcohol first.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- Have other causes of liver problems been excluded, including alcohol and viral hepatitis?
- Which fibrosis tests are you using, and what do my results suggest about scarring?
- What is my risk of advanced scarring, and what would change it?
- What lifestyle changes would help my liver most, and what support is available?
- How are my diabetes, blood pressure and cholesterol affecting my liver and heart?
- How often should my fibrosis risk be reassessed, and who will do it?
- When would I need to see a liver specialist?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my test, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this test not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Is fatty liver disease serious?
Why is it now called MASLD instead of NAFLD?
Can fatty liver be reversed?
Will a blood test tell me if I have scarring?
Do I need a liver biopsy?
Is there a medicine for fatty liver?
Is fatty liver assessed on the NHS?
Find a verified specialist for fatty liver disease assessment
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NICE NG49 — Non-alcoholic fatty liver disease (NAFLD): assessment and management NICE NG49 — Recommendations (ELF testing and fibrosis assessment) British Liver Trust — Tests, diagnosis and screening British Liver Trust — Transient elastography (FibroScan) British Society of Gastroenterology — Guidelines on the management of abnormal liver blood tests
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Liver blood tests · Liver screen (non-invasive liver assessment) · Liver ultrasound scan · MRI liver scan (including MRCP) · Liver specialist (hepatology) appointment